18 nuovi farmaci in commercio

Nuove specialità medicinali: Demelora, Fastuflex, Glyxambi, Laila, Nebivololo Idroclorotiazide Sandoz, Ortodermina, Safubref, Trazimera.5 nuovi farmaci equivalenti

Nuove specialità medicinali
DEMELORA 30 cerotti transdermici 4,6 mg/24h rivastigmina
NEURAXPHARM AIC:041261025 50,29€ Cnn/RRL in commercio dal:25/10/2019

DEMELORA 30 cerotti transdermici 9,5 mg/24h rivastigmina
NEURAXPHARM AIC:041261064 54,73€ Cnn/RRL in commercio dal:25/10/2019

FASTUFLEX 10 cerotti medicati 180 mg diclofenac idrossietilpirrolidina (diclofenac epolamina)
A.MENARINI AIC:045952025 – C/OTC in commercio dal:08/10/2019

FASTUFLEX 5 cerotti medicati 180 mg diclofenac idrossietilpirrolidina (diclofenac epolamina)
A.MENARINI AIC:045952013 – C/OTC in commercio dal:08/10/2019

GLYXAMBI 30 cpr riv 10 mg + 5 mg empagliflozin/linagliptin
BOEHRINGER INGELHEIM AIC:045183050 101,17€ A/RRL in commercio dal:06/10/2019

GLYXAMBI 30 cpr riv 25 mg + 5 mg empagliflozin/linagliptin
BOEHRINGER INGELHEIM AIC:045183148 101,17€ A/RRL in commercio dal:06/10/2019

LAILA 14 cps molli lavanda essenza
DR.WILLMAR SCHWABE GmbH&CO.KG AIC:044460018 – C/SOP in commercio dal:08/10/2019

LAILA 28 cps molli lavanda essenza
DR.WILLMAR SCHWABE GmbH&CO.KG AIC:044460020 – C/SOP in commercio dal:08/10/2019

NEBIVOLOLO IDROCLOROTIAZIDE SANDOZ 28 cpr 5 mg + 12,5 mg nebivololo cloridrato/idroclorotiazide
SANDOZ AIC:044999011 5,97€ A/RR in commercio dal:10/10/2019

NEBIVOLOLO IDROCLOROTIAZIDE SANDOZ 28 cpr 5 mg + 25 mg nebivololo cloridrato/idroclorotiazide
SANDOZ AIC:044999023 5,97€ A/RR in commercio dal:10/10/2019

ORTODERMINA crema 3 g 5% lidocaina cloridrato
SOFAR AIC:005556030 – C/SOP in commercio dal:22/10/2019

SAFUBREF 60 dosi 50 mcg + 500 mcg salmeterolo xinafoato/fluticasone propionato
ORION CORPORATION AIC:045961048 45,24€ A/RR in commercio dal:23/10/2019

TRAZIMERA EV polv 1 flaconcino 150 mg trastuzumab
PFIZER AIC:046922011 736,10€ H/RNRL in commercio dal:10/10/2019

Nuovi farmaci equivalenti
CASPOFUNGIN SUN EV flaconcino 50 mg caspofungin acetato
RANBAXY AIC:044438012 403,90€ H/OSP in commercio dal:15/10/2019

CASPOFUNGIN SUN EV flaconcino 70 mg caspofungin acetato
RANBAXY AIC:044438024 513,75€ H/OSP in commercio dal:15/10/2019

SIMVASTATINA TEVA ITALIA 28 cpr riv 10 mg simvastatina
TEVA AIC:041581137 2,97€ A/RR in commercio dal:10/10/2019

VENLAFAXINA TEVA ITALIA 28 cps 150 mg rilascio prolungato venlafaxina cloridrato
TEVA AIC:038500221 18,41€ A/RR in commercio dal:10/10/2019

VENLAFAXINA TEVA ITALIA 28 cps 75 mg rilascio prolungato venlafaxina cloridrato
TEVA AIC:038500132 9,18€ A/RR in commercio dal:10/10/2019

Farmaci: 5 variazioni di classe
Emicrania acuta, l'Fda approva il lasmiditan, farmaco di ricerca Eli Lilly

Flash news simili

Editoriali

L’esperto risponde